Last reviewed · How we verify
NCT04468386
Specimen Collection Study Protocol
trial in Focus in on Collecting Paired Specimens for Matrix Equivalency in 47 participants. Completed in 30 May 2021.
30 May 2021
Quick facts
| Lead sponsor | Biomerica |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 47 |
| Start date | 7 July 2020 |
| Primary completion | 30 May 2021 |
| Estimated completion | 30 May 2021 |
| Sites | 1 location across United States |
Conditions studied
- Focus in on Collecting Paired Specimens for Matrix Equivalency — all drugs for Focus in on Collecting Paired Specimens for Matrix Equivalency →
Sponsor
Biomerica
Who can join
21 and older, any sex, with Focus in on Collecting Paired Specimens for Matrix Equivalency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The specimens collected will be used to evaluate matrix equivalency in an immunoassay in development for the detection of IgG or IgA or IgM antibodies to SARS - CoV2 in human serum. These reagents are for in vitro diagnostic use only.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04468386
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Biomerica trials
Trials by the same sponsor.
- NCT03459482 — Endpoint Determination Study Protocol · NA · completed
- NCT02970110 — Specimen Collection Study for H. Pylori Testing · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04468386 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biomerica
- Last refreshed: 24 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04468386.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing